Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group

Katherine Tarlock; Todd A. Alonzo; Pilar P. Moraleda; Robert B. Gerbing; Susana C. Raimondi; Betsy A. Hirsch; Yaddanapudi Ravindranath; Beverly Lange; William G. Woods; Alan S. Gamis; Soheil Meshinchi

doi:10.1111/bjh.12852

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group

Katherine Tarlock, Todd A. Alonzo, Pilar P. Moraleda, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Yaddanapudi Ravindranath, Beverly Lange, William G. Woods, Alan S. Gamis, Soheil Meshinchi

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

Summary: Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a rare subtype associated with FLT3-internal tandem duplication (ITD) and poor outcomes. The clinical outcomes of paediatric patients with t(6;9) with and without FLT3-ITD treated on six consecutive cooperative trails were evaluated. In contrast to patients without t(6;9), those with t(6;9) had a significantly lower complete remission rate, higher relapse rate (RR), and poor overall survival (OS). Within t(6;9) patients, those with and without FLT3-ITD had an OS of 40% and 27% respectively (P > 0·9), demonstrating that t(6;9) is a high-risk cytogenetic feature in paediatric AML and its clinical impact is independent of the presence of FLT3-ITD.

Original language	English (US)
Pages (from-to)	254-259
Number of pages	6
Journal	British journal of haematology
Volume	166
Issue number	2
DOIs	https://doi.org/10.1111/bjh.12852
State	Published - Jul 2014

Keywords

Acute myeloid leukaemia
Clinical outcome
FLT3-ITD
Paediatric
T(6; 9)(p23; q34)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1111/bjh.12852

Find It

Find It at U of M Libraries

Cite this

Tarlock, K., Alonzo, T. A., Moraleda, P. P., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Ravindranath, Y., Lange, B., Woods, W. G., Gamis, A. S., & Meshinchi, S. (2014). Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group. British journal of haematology, 166(2), 254-259. https://doi.org/10.1111/bjh.12852

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group. / Tarlock, Katherine; Alonzo, Todd A.; Moraleda, Pilar P. et al.
In: British journal of haematology, Vol. 166, No. 2, 07.2014, p. 254-259.

Research output: Contribution to journal › Article › peer-review

Tarlock, K, Alonzo, TA, Moraleda, PP, Gerbing, RB, Raimondi, SC, Hirsch, BA, Ravindranath, Y, Lange, B, Woods, WG, Gamis, AS & Meshinchi, S 2014, 'Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group', British journal of haematology, vol. 166, no. 2, pp. 254-259. https://doi.org/10.1111/bjh.12852

@article{9e7090df4c5643af9c7cdb475818bf10,

title = "Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group",

abstract = "Summary: Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a rare subtype associated with FLT3-internal tandem duplication (ITD) and poor outcomes. The clinical outcomes of paediatric patients with t(6;9) with and without FLT3-ITD treated on six consecutive cooperative trails were evaluated. In contrast to patients without t(6;9), those with t(6;9) had a significantly lower complete remission rate, higher relapse rate (RR), and poor overall survival (OS). Within t(6;9) patients, those with and without FLT3-ITD had an OS of 40% and 27% respectively (P > 0·9), demonstrating that t(6;9) is a high-risk cytogenetic feature in paediatric AML and its clinical impact is independent of the presence of FLT3-ITD.",

keywords = "Acute myeloid leukaemia, Clinical outcome, FLT3-ITD, Paediatric, T(6; 9)(p23; q34)",

author = "Katherine Tarlock and Alonzo, {Todd A.} and Moraleda, {Pilar P.} and Gerbing, {Robert B.} and Raimondi, {Susana C.} and Hirsch, {Betsy A.} and Yaddanapudi Ravindranath and Beverly Lange and Woods, {William G.} and Gamis, {Alan S.} and Soheil Meshinchi",

year = "2014",

month = jul,

doi = "10.1111/bjh.12852",

language = "English (US)",

volume = "166",

pages = "254--259",

journal = "British journal of haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status

T2 - A report from the Children's Oncology Group

AU - Tarlock, Katherine

AU - Alonzo, Todd A.

AU - Moraleda, Pilar P.

AU - Gerbing, Robert B.

AU - Raimondi, Susana C.

AU - Hirsch, Betsy A.

AU - Ravindranath, Yaddanapudi

AU - Lange, Beverly

AU - Woods, William G.

AU - Gamis, Alan S.

AU - Meshinchi, Soheil

PY - 2014/7

Y1 - 2014/7

N2 - Summary: Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a rare subtype associated with FLT3-internal tandem duplication (ITD) and poor outcomes. The clinical outcomes of paediatric patients with t(6;9) with and without FLT3-ITD treated on six consecutive cooperative trails were evaluated. In contrast to patients without t(6;9), those with t(6;9) had a significantly lower complete remission rate, higher relapse rate (RR), and poor overall survival (OS). Within t(6;9) patients, those with and without FLT3-ITD had an OS of 40% and 27% respectively (P > 0·9), demonstrating that t(6;9) is a high-risk cytogenetic feature in paediatric AML and its clinical impact is independent of the presence of FLT3-ITD.

AB - Summary: Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is a rare subtype associated with FLT3-internal tandem duplication (ITD) and poor outcomes. The clinical outcomes of paediatric patients with t(6;9) with and without FLT3-ITD treated on six consecutive cooperative trails were evaluated. In contrast to patients without t(6;9), those with t(6;9) had a significantly lower complete remission rate, higher relapse rate (RR), and poor overall survival (OS). Within t(6;9) patients, those with and without FLT3-ITD had an OS of 40% and 27% respectively (P > 0·9), demonstrating that t(6;9) is a high-risk cytogenetic feature in paediatric AML and its clinical impact is independent of the presence of FLT3-ITD.

KW - Acute myeloid leukaemia

KW - Clinical outcome

KW - FLT3-ITD

KW - Paediatric

KW - T(6; 9)(p23; q34)

UR - http://www.scopus.com/inward/record.url?scp=84903739416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903739416&partnerID=8YFLogxK

U2 - 10.1111/bjh.12852

DO - 10.1111/bjh.12852

M3 - Article

C2 - 24661089

AN - SCOPUS:84903739416

SN - 0007-1048

VL - 166

SP - 254

EP - 259

JO - British journal of haematology

JF - British journal of haematology

IS - 2

ER -

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: A report from the Children's Oncology Group

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this